MERCK KGAA

Aulos Bioscience announced dosing of the first patient with AU-007, avelumab, and low-dose aldesleukin in a Phase 2 cohort for PD-L1+ NSCLC. This trial is a collaboration with Ares Trading S.A., a Merck KGaA subsidiary, and part of Aulos’ Phase 1/2 clinical trial of AU-007. Preliminary data from the Phase 2 cohort is expected in the first half of 2025.

The National Reimbursement Drug List (NRDL) faces budget pressure and competition, with 445 drugs passing formal review in 2024. Oncology, immunology, neurology, and rare diseases see strategic positioning and comparator choices as key. Contract renewals and re-negotiations are under pressure, emphasizing clear messaging and data preparation for NRDL success.

The Global Cell Counting Market is projected to grow at a CAGR of 6.20% from 2024 to 2031, reaching USD 16.5 Billion. Factors driving growth include increasing demand for accurate diagnostics, advanced biotechnological research, and automation technology.

Dr. Catherine Pickering, CEO of iOnctura, champions targeted cancer treatments and diversity in biotech, focusing on the PI3K pathway and advocating for gender balance in STEM careers.

The cell culture market is projected to grow from $27.66 billion in 2023 to $48.33 billion by 2028, driven by increasing demand for cell therapy and advancements in cell culture technology. Key players are innovating with solutions like the cQrex portfolio to enhance efficiency and productivity.

The global organoids market, valued at $3.3 billion in 2023, is projected to reach $23.8 billion by 2033, driven by healthcare expenditure, chronic diseases, and precision oncology. Key segments include intestinal organoids, drug discovery, biopharmaceutical companies, and pluripotent stem cells. North America leads, but Asia-Pacific and Western Europe will grow fastest. Major players include Thermo Fisher Scientific and Carl Zeiss AG.

The Biotechnology Reagents & Kits Market, valued at USD 563.19 billion in 2023, is projected to grow at a CAGR of 11.04% to USD 1441.03 billion by 2032, driven by demand from diagnostic labs, research institutions, and pharmaceutical companies. Key players include Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, and Roche Diagnostics. The market is segmented by product type, technology, and application, with North America leading and Asia-Pacific showing rapid growth. Recent developments include collaborations and product launches enhancing diagnostic capabilities.

The Mouse Organoid Culture Medium Market is projected to grow from USD 65.64 million in 2024 to USD 115.56 million by 2030, driven by personalized medicine, chronic disease prevalence, and stem cell research advancements. Key market drivers include personalized medicine demand, 3D cell culture techniques, biotech investments, and disease modeling focus. Challenges include high setup costs, culture complexity, and IP issues. Innovations like serum-free media and IoT-enabled bioreactors are recommended for market opportunities. Major players include Abcam, Amsbio, ATCC, and others.

The Apoptosis Assay Market was valued at USD 5.77 Billion in 2023 and is projected to reach USD 12.86 Billion by 2032, growing at a CAGR of 9.37%. Market growth is fueled by advancements in biotechnology and rising healthcare demands, particularly in oncology and immunology. Key players include Thermo Fisher Scientific, Bio-Rad Laboratories, and others. North America leads the market, while Asia Pacific shows rapid growth potential.

The global life science tools market is projected to grow from USD 179.44 billion in 2024 to USD 455.30 billion by 2033, driven by advancements in NMR, chromatography, MS, sequencing, and increased funding for modern therapeutics. Key trends include AI-powered data analysis, multi-omics integration, sustainability initiatives, and growth in cell and gene therapies. North America dominated the market in 2023, while Asia Pacific is expected to grow the fastest. Major companies include Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific.